Sign in
Taking peopleNo phase

Comparison of Low- Versus High-Level Angle Kappa Compensation Strategies in SMILE Using the VisuMax 800: A Randomized Clinical Trial

Key facts

Who runs it
Zhongshan Ophthalmic Center, Sun Yat-sen University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
8 Apr 2026
Expected to end
30 May 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Apply high compensation to the Kappa angle.
  • Apply low compensation to the Kappa angle.
Record updated
7 July 2026

Who can take part

Age
18 years to 40 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Age range: 18 - 40 years old. Patients with stable refractive status for >= 1 year, having myopia or myopic astigmatism, with refractive power within the range of SMILE procedure
  • Normal corneal morphology and corneal thickness meeting the surgical requirements
  • Best corrected visual acuity (CDVA) before surgery >= 1.0
  • The kappa angle-related offset coordinates (x, y) obtained before surgery, with the absolute value of either |x| or |yl| of any eye >= 0.20mm
  • Voluntary to undergo SMILE surgery on the VISUMAX800 platform, understanding the random grouping scheme and signing the informed consent form

Who cannot take part

  • History of prior ocular surgery, significant ocular trauma, or presence of corneal or ocular diseases that may affect the safety of refractive surgery
  • Severe systemic diseases that may affect ocular healing or surgical safety
  • Females who are pregnant or lactating
  • Inability to cooperate as required to complete the procedure or follow-up visits

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 40 years old?

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to compare two intraoperative kappa-angle compensation strategies during small incision lenticule extraction (SMILE) using the VisuMax 800 platform in patients with relatively large kappa-angle offsets.

Read full original descriptionShow less

Angle kappa represents the difference between the visual axis and the pupil center. In patients with a large offset, pupil-centered treatment may lead to decentration of the optical zone, which can induce higher-order aberrations and affect postoperative visual quality. The VisuMax 800 system allows intraoperative adjustment of the treatment center based on the measured offset, making different compensation strategies possible.

The main questions this study aims to answer are:

Does low kappa-angle compensation (50%) result in lower postoperative higher-order aberrations than high compensation (100%)? Does the compensation strategy influence visual acuity, refractive outcomes, contrast sensitivity, and subjective visual quality after SMILE? Are the measurements obtained from different diagnostic devices consistent when evaluating kappa-related parameters?

Researchers will compare SMILE with low compensation to SMILE with high compensation to determine which strategy provides better optical quality and visual performance.

Participants will:

Undergo SMILE surgery using either low or high kappa-angle compensation Complete scheduled postoperative examinations at 1 month, 3 months, and 6 months Receive measurements of visual acuity, refraction, higher-order aberrations, contrast sensitivity, and patient-reported visual outcomes Be monitored for safety outcomes and adverse events during follow-up

The 2 groups in the trial

  • Low-Level compensation groupExisting treatment, for comparison

    Subjects underwent SMILE surgery on the VisuMax 800 platform. Preoperatively, decentration coordinates (x, y) were measured. While preserving the directional sign, the absolute value of the planned compensation was set to 50% of the measured decentration; the values were then rounded to the nearest increment permitted by the device input precision and entered into the system. All other surgical procedures, as well as postoperative medication and follow-up protocols, were performed according to a standardized regimen.

    Treatment: Apply low compensation to the Kappa angle.

  • High-Level compensation groupTreatment being tested

    Subjects also underwent SMILE surgery on the VisuMax 800 platform. Decentration coordinates (x, y) were measured, and the theoretical compensation was set at 100% of the measured decentration. While preserving the directional sign, the measured values were entered directly into the device without any additional adjustment. Except for the different compensation strategy, all other surgical procedures and postoperative management were identical to those of the low-compensation group.

    Treatment: Apply high compensation to the Kappa angle.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07512102, who can take part
Record updated
7 July 2026